Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9249 | 1105 | 47.4 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
14 | 37098 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BETA SECRETASE | Author keyword | 167 | 55% | 19% | 207 |
2 | BACE1 | Author keyword | 126 | 52% | 15% | 169 |
3 | BACE 1 | Author keyword | 89 | 70% | 7% | 74 |
4 | BACE | Author keyword | 66 | 55% | 7% | 82 |
5 | MEMAPSIN 2 | Author keyword | 48 | 100% | 2% | 17 |
6 | BACE1 INHIBITOR | Author keyword | 41 | 87% | 2% | 20 |
7 | BACE2 | Author keyword | 29 | 77% | 2% | 20 |
8 | PROT STUDIES PROGRAM | Address | 27 | 51% | 3% | 38 |
9 | BACE1 INHIBITORS | Author keyword | 21 | 90% | 1% | 9 |
10 | BACE 1 INHIBITORS | Author keyword | 19 | 76% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETA SECRETASE | 167 | 55% | 19% | 207 | Search BETA+SECRETASE | Search BETA+SECRETASE |
2 | BACE1 | 126 | 52% | 15% | 169 | Search BACE1 | Search BACE1 |
3 | BACE 1 | 89 | 70% | 7% | 74 | Search BACE+1 | Search BACE+1 |
4 | BACE | 66 | 55% | 7% | 82 | Search BACE | Search BACE |
5 | MEMAPSIN 2 | 48 | 100% | 2% | 17 | Search MEMAPSIN+2 | Search MEMAPSIN+2 |
6 | BACE1 INHIBITOR | 41 | 87% | 2% | 20 | Search BACE1+INHIBITOR | Search BACE1+INHIBITOR |
7 | BACE2 | 29 | 77% | 2% | 20 | Search BACE2 | Search BACE2 |
8 | BACE1 INHIBITORS | 21 | 90% | 1% | 9 | Search BACE1+INHIBITORS | Search BACE1+INHIBITORS |
9 | BACE 1 INHIBITORS | 19 | 76% | 1% | 13 | Search BACE+1+INHIBITORS | Search BACE+1+INHIBITORS |
10 | BACE 1 INHIBITOR | 15 | 88% | 1% | 7 | Search BACE+1+INHIBITOR | Search BACE+1+INHIBITOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYDROXY ETHYLAMINES HEAS | 86 | 96% | 2% | 26 |
2 | BETA SECRETASE ACTIVITY | 70 | 58% | 7% | 80 |
3 | HUMAN BETA SECRETASE | 62 | 80% | 4% | 39 |
4 | BETA SECRETASE INHIBITORS | 58 | 75% | 4% | 42 |
5 | CLEAVING ENZYME | 53 | 48% | 7% | 82 |
6 | BACE | 51 | 61% | 5% | 54 |
7 | ASPARTYL PROTEASE | 49 | 42% | 8% | 90 |
8 | ALZHEIMERS BETA SECRETASE | 43 | 69% | 3% | 37 |
9 | BACE1 | 33 | 38% | 6% | 69 |
10 | BETA SECRETASE | 28 | 18% | 13% | 139 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting the beta secretase BACE1 for Alzheimer's disease therapy | 2014 | 46 | 63 | 79% |
Developing ss-secretase inhibitors for treatment of Alzheimer's disease | 2012 | 82 | 72 | 90% |
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects | 2014 | 24 | 202 | 47% |
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease | 2014 | 13 | 204 | 77% |
beta-secretase as a therapeutic target for Alzheimer's disease | 2008 | 90 | 64 | 94% |
Identification and biology of ss-secretase | 2012 | 35 | 83 | 81% |
The secretases: enzymes with therapeutic potential in Alzheimer disease | 2010 | 202 | 108 | 28% |
The beta-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease | 2011 | 31 | 73 | 86% |
The Role of Amyloid Precursor Protein Processing by BACE1, the beta-Secretase, in Alzheimer Disease Pathophysiology | 2008 | 93 | 56 | 75% |
Advances in the identification of beta-secretase inhibitors | 2013 | 8 | 104 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROT STUDIES PROGRAM | 27 | 51% | 3.4% | 38 |
2 | PROTEOM SCI | 4 | 67% | 0.4% | 4 |
3 | GLYCO CHAIN FUNCT | 3 | 50% | 0.5% | 5 |
4 | VAH GRECC | 3 | 100% | 0.3% | 3 |
5 | PEPTIDE SCI | 3 | 35% | 0.6% | 7 |
6 | HALDEMAN MOL DIAGNOST THER EUT | 3 | 60% | 0.3% | 3 |
7 | DEMYELINATING DIS AGEING | 2 | 67% | 0.2% | 2 |
8 | SUPRABIOMOL SYST GRPFRONTIER SYST | 2 | 67% | 0.2% | 2 |
9 | TOWNSEND FAMILY S PSYCHIAT | 2 | 67% | 0.2% | 2 |
10 | OKLAHOMA MED FDN | 2 | 11% | 1.5% | 17 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195823 | PRESENILIN//GAMMA SECRETASE//PRESENILIN 1 |
2 | 0.0000122311 | AMYLOID PRECURSOR PROTEIN//BETA AMYLOID PRECURSOR PROTEIN//AMYLOID PRECURSOR LIKE PROTEIN |
3 | 0.0000113414 | BAPINEUZUMAB//INTRANEURONAL ABETA//SOLANEZUMAB |
4 | 0.0000108115 | FE65//ALCADEIN//X11 ALPHA |
5 | 0.0000106258 | FAMILIAL DANISH DEMENTIA//BRI2//GLUTAMINYL CYCLASE |
6 | 0.0000070193 | MEMORY AND LEARNING IMPAIRMENT//ALZHEIMER KOR KUTATOCSOPORT//FLAP PROTEIN |
7 | 0.0000057459 | PSYCHIAT NEUROCHEM//CLIN MEMORY UNIT//UNIT NEUROCHEM |
8 | 0.0000052019 | 24S HYDROXYCHOLESTEROL//CYP46//24 HYDROXYCHOLESTEROL |
9 | 0.0000051046 | SORL1//TOMM40//PICALM |
10 | 0.0000045253 | NMR SCREENING//FRAGMENT BASED DRUG DISCOVERY//WATERLOGSY |